OraSure Technologies | OSUR - Gross Profit On Sales


OraSure Technologies reported $11.34M in Gross Profit on Sales for its fiscal quarter ending in December of 2025.





Gross Profit On Sales Change Date
Agilent USD 946M 44M Dec/2025
AngioDynamics USD 44.78M 2.93M Sep/2025
Becton, Dickinson and Co. USD 2.41B 1.72B Dec/2025
Bio Techne USD 191.28M 3.16M Dec/2025
Bio-Rad Laboratories USD 345.2M 1.8M Dec/2025
Bruker USD 449.2M 69.8M Dec/2025
Cerus USD 33.33M 8.66M Dec/2024
Charles River Laboratories USD 271.96M 39.43M Dec/2025
Danaher USD 3.59B 375M Mar/2026
Dentsply International USD 443M 2M Dec/2025
Dexcom USD 750.3M 42.4M Mar/2026
Illumina USD 721M 38M Mar/2026
Integra LifeSciences USD 213.21M 3.89M Mar/2026
Intuitive Surgical USD 1.83B 73.8M Mar/2026
IQVIA Holdings USD 1.12B 32M Dec/2025
Mesa Laboratories USD 39.75M 4.3M Dec/2024
Mettler Toledo International USD 675.44M 65.98M Dec/2025
Myriad Genetics USD 146.8M 3M Dec/2025
OraSure Technologies USD 11.34M 435K Dec/2025
Quidel USD 274.8M 1.01B Dec/2025
Repligen USD 103.83M 3.32M Dec/2025
Revvity USD 387.66M 34M Mar/2026
STAAR Surgical USD 43.74M 34.13M Dec/2025
Thermo Fisher Scientific USD 4.49B 146M Mar/2026
Trinity Biotech USD 6.47M 1.59M Sep/2025
Waters USD 557.42M 97.44M Dec/2025